These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24955450)

  • 21. Efficacy and safety comparative study of dexrabeprazole vs. esomeprazole for the treatment of gastroesophageal reflux disease.
    Abdo-Francis JM; Cabrera-Álvarez G; Martínez-Torres H; Remes-Troche JM
    Gac Med Mex; 2022; 158(6):423-429. PubMed ID: 36657136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study.
    Gunasekaran T; Tolia V; Colletti RB; Gold BD; Traxler B; Illueca M; Crawley JA
    BMC Gastroenterol; 2009 Nov; 9():84. PubMed ID: 19922626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].
    Maev IV; Viuchnova ES; Balashova NN; Shchekina MI
    Eksp Klin Gastroenterol; 2003; (3):26-31, 116. PubMed ID: 14556543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
    Bayerdörffer E; Bigard MA; Weiss W; Mearin F; Rodrigo L; Dominguez Muñoz JE; Grundling H; Persson T; Svedberg LE; Keeling N; Eklund S
    BMC Gastroenterol; 2016 Apr; 16():48. PubMed ID: 27080034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
    Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26121345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life.
    Takeshima F; Hashiguchi K; Onitsuka Y; Tanigawa K; Minami H; Matsushima K; Akazawa Y; Shiozawa K; Yamaguchi N; Taura N; Ohnita K; Ichikawa T; Isomoto H; Nakao K
    Med Sci Monit; 2015 Dec; 21():4111-21. PubMed ID: 26719012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial.
    Wang L; Zhong Z; Hu J; Rong X; Liu J; Xiao S; Liu Z
    BMC Psychiatry; 2015 Apr; 15():84. PubMed ID: 25879863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of depressive anxiety states associated with psychosomatic symptoms. A double-blind multicentre clinical study: mianserin versus melitracen-flupentixol.
    Van Moffaert M; Dierick M; De Meulemeester F; Vereecken A
    Acta Psychiatr Belg; 1983; 83(5):525-39. PubMed ID: 6670581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and Safety of Flupentixol and Melitracen Tablets for the Treatment of Patients with Persistent Idiopathic Facial Pain: A Retrospective Observational Study.
    Wang Y; Shrestha N; Shen Y; Luo F
    Pain Physician; 2024 May; 27(4):263-272. PubMed ID: 38805533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect analysis on Deanxit combined with Shuganjieyu capsule in the treatment of refractory gastroesophageal reflux disease].
    Yang XY; Guo CY; Zhang X; Zhong YQ; Tian C
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3475-3479. PubMed ID: 29275582
    [No Abstract]   [Full Text] [Related]  

  • 33. [The impact of proton pump inhibitors on esophageal acid exposure in gastroesophageal reflux disease].
    Liang XY; Chen WN; Lan L; Wang Q; Lü YW; Lan Y
    Zhonghua Nei Ke Za Zhi; 2012 Jul; 51(7):513-5. PubMed ID: 22943821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological modulation in patients surgically intervened for gastroesophageal reflux disease.
    Lara FJ; Carranque G; Oehling H; Hernández JM; Oliva H
    Dis Esophagus; 2014 Aug; 27(6):538-46. PubMed ID: 23121479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease.
    Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):524-33. PubMed ID: 18493207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
    Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.
    Liang CM; Kuo MT; Hsu PI; Kuo CH; Tai WC; Yang SC; Wu KL; Wang HM; Yao CC; Tsai CE; Wang YK; Wang JW; Huang CF; Wu DC; Chuah SK;
    World J Gastroenterol; 2017 Dec; 23(47):8395-8404. PubMed ID: 29307999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
    Bajbouj M; Becker V; Phillip V; Wilhelm D; Schmid RM; Meining A
    Digestion; 2009; 80(2):112-8. PubMed ID: 19641320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esomeprazole for the Treatment of GERD in Infants Ages 1-11 Months.
    Winter H; Gunasekaran T; Tolia V; Gottrand F; Barker PN; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S9-15. PubMed ID: 26422097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pantoprazole 40 mg is as effective as esomeprazole 40 mg to relieve symptoms of gastroesophageal reflux disease after 4 weeks of treatment and superior regarding the prevention of symptomatic relapse.
    Glatzel D; Abdel-Qader M; Gatz G; Pfaffenberger B
    Digestion; 2007; 75 Suppl 1():69-78. PubMed ID: 17489035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.